Home › Alzheimer's Disease › Ohio › Dayton
Alzheimer's Disease clinical trials in Dayton, OH
6 studies for Alzheimer's Disease are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Dayton
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecruitingPhase 3
- Local Institution - 1258, Dayton
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
RecruitingPhase 2
- NDx Clinical Research, Dayton
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- NDx Clinical Research Inc., Dayton
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- NDx Clinical Research, Inc., Dayton
[18F]PI-2620 Phase 3 Histopathological Study
RecruitingPhase 3
- Valley Medical Research, Centerville · 9 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- The Villages, FL15 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Dayton
- Lung Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Steatotic Liver Disease8 studies
- Heart Failure8 studies
- Melanoma7 studies
- Cancer (all types)7 studies
- Endometrial Cancer7 studies
- Breast Cancer7 studies
- Prostate Cancer7 studies
- Obesity7 studies
- Overweight6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.